ROIV — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

5.44

Margin Of Safety %

Put/Call OI Ratio

1.2

EPS Next Q Diff

0.03

EPS Last/This Y

-0.73

EPS This/Next Y

-0.19

Price

29.4

Target Price

35.67

Analyst Recom

1.29

Performance Q

7.46

Upside

-151.8%

Beta

1.14

Ticker: ROIV

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-13	ROIV	28.95	0.75	0.61	33618
2026-04-14	ROIV	29.12	0.75	0.21	34374
2026-04-15	ROIV	29.39	0.75	0.00	34392
2026-04-16	ROIV	29.19	0.75	0.03	34431
2026-04-17	ROIV	29.8	0.74	8.79	34538
2026-04-20	ROIV	29.08	0.81	4.51	33570
2026-04-21	ROIV	29.28	0.83	2.88	33977
2026-04-22	ROIV	29.15	0.85	0.27	34730
2026-04-23	ROIV	28.13	0.85	2.58	34735
2026-04-24	ROIV	27.39	0.88	0.36	35008
2026-04-27	ROIV	27.84	0.88	0.25	35038
2026-04-28	ROIV	27.77	0.88	1.50	35044
2026-04-29	ROIV	27.51	0.88	0.94	35056
2026-04-30	ROIV	28.53	0.88	0.07	35101
2026-05-01	ROIV	27.84	0.88	1.00	35149
2026-05-04	ROIV	28.36	0.88	1.19	35150
2026-05-05	ROIV	28.32	0.88	0.23	35175
2026-05-06	ROIV	28.81	0.88	1.95	35301
2026-05-07	ROIV	28.28	0.88	0.63	35528
2026-05-08	ROIV	28.57	0.88	0.03	35558
2026-05-11	ROIV	28.95	1.20	0.01	30548
2026-05-12	ROIV	29.4	1.20	0.07	30547
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-13	ROIV	28.95	-60.2	-	-0.97
2026-04-14	ROIV	29.11	-60.2	-	-0.97
2026-04-15	ROIV	29.40	-60.2	-	-0.97
2026-04-16	ROIV	29.21	-60.2	-	-0.97
2026-04-17	ROIV	29.81	-60.2	-	-0.97
2026-04-20	ROIV	29.09	-60.2	-	-0.97
2026-04-21	ROIV	29.28	-60.2	-	-0.97
2026-04-22	ROIV	29.15	-60.2	-	-0.97
2026-04-23	ROIV	28.13	-60.2	-	-0.97
2026-04-24	ROIV	27.40	-60.2	-	-0.97
2026-04-27	ROIV	27.85	-60.2	-	-0.97
2026-04-28	ROIV	27.77	-60.2	-	-0.97
2026-04-29	ROIV	27.51	-60.2	-	-0.97
2026-04-30	ROIV	28.53	-60.2	-	-0.97
2026-05-01	ROIV	27.83	-60.2	-	-0.97
2026-05-04	ROIV	28.35	-60.2	-	-0.97
2026-05-05	ROIV	28.32	-60.2	-	-0.97
2026-05-06	ROIV	28.81	-60.2	-	-0.97
2026-05-07	ROIV	28.29	-60.2	-	-0.97
2026-05-08	ROIV	28.56	-60.2	-	-0.97
2026-05-11	ROIV	28.96	-60.2	-	-0.97
2026-05-12	ROIV	29.40	-60.2	-	-0.97
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-13	ROIV	-10.56	2.15	5.10
2026-04-14	ROIV	-10.56	2.15	5.10
2026-04-15	ROIV	-10.52	2.15	5.10
2026-04-17	ROIV	-10.52	2.15	5.10
2026-04-20	ROIV	-10.22	2.11	5.10
2026-04-21	ROIV	-10.32	2.11	5.10
2026-04-22	ROIV	-10.32	2.11	5.10
2026-04-23	ROIV	-10.39	2.11	5.10
2026-04-24	ROIV	-10.39	2.11	5.10
2026-04-27	ROIV	-10.39	0.45	5.00
2026-04-28	ROIV	-10.42	0.45	5.00
2026-04-29	ROIV	-10.42	0.45	5.00
2026-04-30	ROIV	-10.42	0.45	5.00
2026-05-01	ROIV	-10.42	0.45	5.00
2026-05-04	ROIV	-10.42	-1.36	5.00
2026-05-05	ROIV	-10.42	-1.36	5.00
2026-05-06	ROIV	-10.42	-1.36	5.00
2026-05-07	ROIV	-10.42	-1.36	5.00
2026-05-08	ROIV	-10.35	-1.36	5.00
2026-05-11	ROIV	-10.35	-1.97	4.92
2026-05-12	ROIV	-10.70	-1.97	5.44
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.36

Avg. EPS Est. Current Quarter

-0.31

Avg. EPS Est. Next Quarter

-0.33

Insider Transactions

-10.7

Institutional Transactions

-1.97

Beta

1.14

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

3.1

Max Drawdown 5-Year %

Target Price

35.67

P/E

Forward P/E

PEG

P/S

1580.35

P/B

4.89

P/Free Cash Flow

EPS

-1.17

Average EPS Est. Cur. Y

-0.97

EPS Next Y. (Est.)

-1.16

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-6079.94

Relative Volume

1.55

Return on Equity vs Sector %

-45.8

Return on Equity vs Industry %

-30.3

EPS 1 7Days Diff

EPS 1 30Days Diff

0.12

EBIT Estimation

◆ ROIV Healthcare

$29.39

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

20/20

Pullback

8/25

Volume

3/15

Valuation

6/20

TP/AR

4/10

Options

2/10

RSI

58.5

Range 1M

74.4%

Sup Dist

2.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

13/25

Growth

4/30

Estimates

3/20

Inst/Vol

5/15

Options

6/10

EPS Yr

-367.2%

EPS NY

-5.5%

52W%

95.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +21.4% upside

Quality

7/30

Valuation

6/30

Growth

1/25

Stability

6/10

LT Trend

4/5

Upside

+21.4%

Quality

Roivant Sciences Ltd.

Sector: Healthcare

Industry: Biotechnology

Employees: 750

Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody that targets the neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising lipid nanoparticle (LNP) platform and ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.

ROIV

Latest News

—

Caricamento notizie per ROIV…

stock quote shares ROIV – Roivant Sciences Ltd Stock Price stock today

news today ROIV – Roivant Sciences Ltd stock forecast ,stock prediction 2023 2024 2025

marketwatch ROIV – Roivant Sciences Ltd yahoo finance google finance

stock history ROIV – Roivant Sciences Ltd invest stock market

stock prices ROIV premarket after hours

ticker ROIV fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ROIV

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y